Haplo SCD Consortium
Non-Profit & Charitable Organizations · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesRevenue
$8.1 MillionIndustry
About Haplo SCD Consortium
Haplo SCD Consortium Org Chart
Is Haplo SCD Consortium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Haplo SCD Consortium launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Haplo SCD Consortium has recently received funding, and reach out quickly before it becomes old news!
Click to see if Haplo SCD Consortium had a recent Job posting/layoffs
Haplo SCD Consortium, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Haplo SCD Consortium recently announced quarterly report
Check out if Haplo SCD Consortium is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Haplo SCD Consortium
Funding: Get notified immidiatlly once Haplo SCD Consortium has new funding data
Recommended Actions
Reach out to Masked Content who joined Haplo SCD Consortium as Masked Content
Find 3 more new buyers
Compare Similar Companies to Haplo SCD Consortium
Compare insights from companies similar to Haplo SCD Consortium, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Haplo SCD Consortium Tech Stack
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding Haplo SCD Consortium
The Haplo SCD Consortium is a multi-institutional organization dedicated to providing resources for families, patients, and healthcare professionals involved in Parent-to-Child (Haplo) Bone Marrow Transplants aimed at curing sickle cell disease in children. They offer clinical trials focused on the safety and efficacy of treatments for sickle cell... Read More